Compassionate use of amphotericin B lipid complex (Abelcet) in life-threatening fungal infections: report of 30 courses
- 1 April 1998
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 4 (4), 192-198
- https://doi.org/10.1111/j.1469-0691.1998.tb00668.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycosesBone Marrow Transplantation, 1997
- Amphotericin B Lipid Complex (Abelcet®) in the treatment of invasive mycoses: the North American experienceEuropean Journal of Haematology, 1996
- Limited Toxicity of Prolonged Therapy with High Doses of Amphotericin B Lipid ComplexClinical Infectious Diseases, 1995
- Administering amphotericin B—a practical approachJournal of Antimicrobial Chemotherapy, 1994
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- Amphotericin B lipid complex therapy of experimental fungal infections in miceAntimicrobial Agents and Chemotherapy, 1991
- Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patientsJournal of Antimicrobial Chemotherapy, 1991
- Amphotericin B NephrotoxicityDrug Safety, 1990
- Criteria for Evaluation of Therapeutic Response to Antifungal DrugsClinical Infectious Diseases, 1980